Establishment of enzyme-linked immunosorbent facilitated antigen binding as a biomarker assay for Japanese cedar pollen allergy immunotherapy

Establishment of enzyme-linked immunosorbent facilitated antigen binding as a biomarker assay for Japanese cedar pollen allergy immunotherapy

Background: Clinical efficacy of allergen-specific Immunotherapy (AIT) towards Japanese cedar (JC) pollen allergy is firmly established but JC pollen-specific biomarker assays are lacking. Treatment-related increase of allergen-specific antibodies is a robust biomarker of successful AIT. Allergen-sp...

Full description

Bibliographic Details
Main Authors:	Chiharu Fukano, Katsuyo Ohashi-Doi, Kaare Lund, Atsuhito Nakao, Keisuke Masuyama, Tomokazu Matsuoka
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319356762

Similar Items

Immunological changes over three years treatment with Japanese cedar SLIT drops in mono-sensitized and poly-sensitized individuals
by: Tomokazu Matsuoka, et al.
Published: (2022-07-01)

Analysis of Helper T Cell Responses to Cry j 1-Derived Peptides in Patients with Nasal Allergy: Candidate for Peptide-Based Immunotherapy of Japanese Cedar Pollinosis
by: Keisuke Masuyama, et al.
Published: (2009-01-01)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
by: Shoko Ueda, et al.
Published: (2022-03-01)

Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress
by: Syuji Yonekura, et al.
Published: (2022-01-01)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
by: Tomoya Kurokawa, MD, PhD, et al.
Published: (2023-05-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
by: Daiju Sakurai, et al.
Published: (2022-11-01)

Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet
by: Minoru Gotoh, et al.
Published: (2020-01-01)

Specificity of an Enzyme-1 Inked Immunosorbent Assay for Dog Ige Antibody to Japanese Cedar (Cryptomeria Japonica) Pollen
by: Masahiro Sakaguchi, et al.
Published: (1997-01-01)

Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen
by: Kei-ichi Yamanaka, et al.
Published: (2015-01-01)

HLA class II association with Type I allergy to house dust mite and Japanese cedar pollen in Japanese subjects
by: Yasuaki Sadanaga, et al.
Published: (1998-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01)

An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis
by: Syuji Yonekura, et al.
Published: (2018-04-01)

A novel approach of preventing Japanese cedar pollen dispersal that is the cause of Japanese cedar pollinosis (JCP) using pollen-specific fungal infection.
by: Yuuri Hirooka, et al.
Published: (2013-01-01)

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets
by: Takashi Yamamoto, PhD, et al.
Published: (2022-01-01)

Changes of Micro-RNAs in Asymptomatic Subjects Sensitized to Japanese Cedar Pollen after Prophylactic Sublingual Immunotherapy
by: Bo Hou M.D., et al.
Published: (2015-03-01)

Cha o 3, a cypress pollen allergen, does not activate basophils in Japanese cypress pollinosis
by: Yoshiaki Kobayashi, MD, et al.
Published: (2024-02-01)

Patterns of Drug Prescription for Japanese Cedar Pollinosis Using a Clinical Vignette Questionnaire
by: Goro Takahashi, et al.
Published: (2008-01-01)

Effect of Antihistamine Eye Drops on the Conjunctival Provocation Test with Japanese Cedar Pollen Allergen
by: Yoshihiro Dake, et al.
Published: (2006-01-01)

Measurement of Japanese Cedar Pollen-Specific IgE in Nasal Secretions
by: Hiroshi Sakaida, et al.
Published: (2014-01-01)

Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergy.
by: Yuhya Wakasa, et al.
Published: (2015-01-01)

Possibility of Japanese Cedar Pollen Causing False Positives in the Deep Mycosis Test
by: Takashi Kanno, et al.
Published: (2021-02-01)

Relationships among indoor, outdoor, and personal airborne Japanese cedar pollen counts.
by: Naomichi Yamamoto, et al.
Published: (2015-01-01)

A Clinical Study of Japanese Cedar (Cryptomeria japonica) Pollen-Induced Asthma
by: Yuji Maeda, et al.
Published: (2008-01-01)

Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
by: Qingliang Kong, et al.
Published: (2020-03-01)

Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons
by: Syuji Yonekura, et al.
Published: (2019-10-01)

Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial
by: Yasuyuki Nomura, et al.
Published: (2021-01-01)

A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Investigation of Cry J1 and Cry J2 Concentrations in Japanese Cedar Pollen and Non-Pollen Seasons
by: Hiroki Tomizawa, et al.
Published: (2022-03-01)

Next generation immunotherapy for tree pollen allergies
by: Yan Su, et al.
Published: (2017-10-01)

Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar–specific ASIT
by: Toshihiro Osada, et al.
Published: (2018-10-01)

The Relationship between Pollen Count Levels and Prevalence of Japanese Cedar Pollinosis in Northeast Japan
by: Kohei Honda, et al.
Published: (2013-01-01)

Omalizumab is Effective and Safe in the Treatment of Japanese Cedar Pollen-induced Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Japanese cedar pollen in floating indoor house dust after a pollinating season
by: Tadao Enomoto, et al.
Published: (2004-01-01)

Circadian Regulation of the Biology of Allergic Disease: Clock Disruption Can Promote Allergy
by: Atsuhito Nakao, et al.
Published: (2020-06-01)

Recognition of T Cell Epitopes Unique to Cha o 2, the Major Allergen in Japanese Cypress Pollen, in Allergic Patients Cross-Reactive to Japanese Cedar and Japanese Cypress Pollen
by: Toshio Sone, et al.
Published: (2009-01-01)

Absence of Nasal Blockage in a Japanese Cedar Pollen-Induced Allergic Rhinitis Model Mouse
by: Hiromi Ogita-Nakanishi, et al.
Published: (2009-01-01)

Investigating Japanese cedar pollen-induced allergic rhinitis and related terms using Google Trends
by: Tomohisa Iinuma, et al.
Published: (2020-10-01)

Continuous 6-Year Follow-Up Study of Sensitization to Japanese Cedar Pollen and Onset in Schoolchildren
by: Atsuko Kanazawa, et al.
Published: (2014-01-01)

Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice
by: Ken Fukuda, et al.
Published: (2018-01-01)